OneMedNet Stock Skyrockets As It Rolls Out Next RWD Phase With Palantir Foundry - OneMedNet ( NASDAQ : ONMD )

<p>OneMedNet <a href="https://www.benzinga.com/quote/ONMD">(NASDAQ:</a><a href="https://www.benzinga.com/quote/ONMD">ONMD</a>) shares are up on Friday following the company’s announcement of <a href="https://www.benzinga.com/pressreleases/26/02/g50926140/onemednet-announces-next-phase-of-commercial-launch-with-its-real-world-data-rwd-platform-powered-">the next phase</a> of its commercial launch for its Real-World Data (RWD) platform, which is powered by Palantir Technologies Inc.’s <a href="https://www.benzinga.com/quote/PLTR">(NASDAQ:</a><a href="https://www.benzinga.com/quote/PLTR">PLTR</a>) Foundry.</p>
<p> • OneMedNet stock is charging ahead with explosive momentum. <a href="https://www.benzinga.com/quote/ONMD">Why are ONMD shares rallying?</a></p>
<p>This development is contributing to a positive sentiment around the stock, even as broader markets are experiencing declines, with the S&amp;P 500 down 0.96%.</p>
<p>“Customer feedback has reinforced the platform’s performance, speed, and depth of discovery,” said CEO Aaron Green. “We believe this traction validates our strategy of combining conversational AI-driven search with scalable, prospective data feeds, strengthening customer confidence as we expand subscriptions and deliver fast, intuitive value for Real-World evidence generation.”</p>
<h2>Trials To Subscriptions</h2>
<p>The company is actively converting customer evaluations into commercial subscriptions, which are expected to drive predictable growth and millions in “incremental” annual recurring revenue (ARR).</p>
<p>With over 2,130 healthcare sites integrated into its iRWD platform, OneMedNet is set to enhance its subscription value through greater scale and real-time access to comprehensive regulatory-grade multimodal data.</p>
<p>The launch is expected to accelerate the adoption of its platform across life sciences and AI health innovators, providing customers with near real-time access to integrated clinical and longitudinal datasets. This strategic move aims to streamline workflows and enhance the speed of evidence generation, reinforcing OneMedNet’s position in the healthcare data landscape.</p>
<p>The broader market is experiencing a mixed day, with major indices like the Dow Jones down 1.41% and the Nasdaq down 0.90%. Despite this, the health care sector is showing some resilience, with a modest gain of 0.26%, indicating that OneMedNet’s positive news may be resonating well within this sector.</p>
<h2>Technical Analysis</h2>
<p>The stock is currently trading 12.5% below its 20-day simple moving average (SMA) and 20% below its 100-day SMA, indicating some short-term weakness. Over the past 12 months, shares have decreased significantly, reflecting broader market challenges, and are currently positioned closer to their 52-week lows than highs.</p>
<p>The RSI is at 50.00, which is considered neutral territory, suggesting the stock is neither overbought nor oversold at this time. Meanwhile, MACD is at 0.10, below its signal line at 0.15, indicating bearish pressure on the stock.</p>
<p>The combination of neutral RSI and bearish MACD suggests mixed momentum, indicating that traders should watch for potential shifts in market sentiment.</p>
<ul>
<li>Key Resistance: $1.50</li>
<li>Key Support: 75 cents</li>
</ul>
<p>Analyst Consensus &amp; Recent Actions: The stock carries a N/A Rating. No recent analyst actions available.</p>
<p>ONMD Price Action: OneMedNet shares were up 81.46% at $1.28 at the time of publication on Friday, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.</p>
<p>
<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom">Market News and Data brought to you by Benzinga APIs</a>
</p>
<p>© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.</p>
<p>To add Benzinga News as your preferred source on Google, <a href="https://google.com/preferences/source?q=https%3A%2F%2Fwww.benzinga.com">click here</a>.</p>